全文获取类型
收费全文 | 144807篇 |
免费 | 11302篇 |
国内免费 | 4132篇 |
专业分类
耳鼻咽喉 | 1393篇 |
儿科学 | 2523篇 |
妇产科学 | 2301篇 |
基础医学 | 10410篇 |
口腔科学 | 3039篇 |
临床医学 | 17564篇 |
内科学 | 20240篇 |
皮肤病学 | 2395篇 |
神经病学 | 14235篇 |
特种医学 | 4394篇 |
外国民族医学 | 39篇 |
外科学 | 14158篇 |
综合类 | 19476篇 |
现状与发展 | 23篇 |
一般理论 | 2篇 |
预防医学 | 5690篇 |
眼科学 | 2228篇 |
药学 | 11118篇 |
76篇 | |
中国医学 | 11372篇 |
肿瘤学 | 17565篇 |
出版年
2024年 | 377篇 |
2023年 | 2664篇 |
2022年 | 4751篇 |
2021年 | 6437篇 |
2020年 | 6123篇 |
2019年 | 5378篇 |
2018年 | 5137篇 |
2017年 | 5568篇 |
2016年 | 5727篇 |
2015年 | 5528篇 |
2014年 | 9995篇 |
2013年 | 12492篇 |
2012年 | 8112篇 |
2011年 | 8804篇 |
2010年 | 7231篇 |
2009年 | 6726篇 |
2008年 | 6647篇 |
2007年 | 7017篇 |
2006年 | 6319篇 |
2005年 | 5583篇 |
2004年 | 4567篇 |
2003年 | 4189篇 |
2002年 | 3446篇 |
2001年 | 2997篇 |
2000年 | 2517篇 |
1999年 | 2019篇 |
1998年 | 1705篇 |
1997年 | 1449篇 |
1996年 | 1213篇 |
1995年 | 1109篇 |
1994年 | 946篇 |
1993年 | 713篇 |
1992年 | 720篇 |
1991年 | 628篇 |
1990年 | 562篇 |
1989年 | 503篇 |
1988年 | 461篇 |
1987年 | 414篇 |
1986年 | 351篇 |
1985年 | 466篇 |
1984年 | 421篇 |
1983年 | 315篇 |
1982年 | 322篇 |
1981年 | 310篇 |
1980年 | 273篇 |
1979年 | 248篇 |
1978年 | 172篇 |
1977年 | 127篇 |
1976年 | 137篇 |
1975年 | 86篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Maxime Lafond Shin Yoshizawa Shin‐ichiro Umemura 《Journal of ultrasound in medicine》2019,38(3):567-580
Sonodynamic therapy (SDT) consists of the synergetic interaction between ultrasound and a chemical agent. In SDT, the cytotoxicity is triggered by ultrasonic stimuli, notably through cavitation. The unique features of SDT are relevant in the clinical context more than ever: the need for efficacy, accuracy, and safety while being noninvasive and preserving the patient's quality of life. However, despite the promising results of this technique, only a few clinical reports describe the use of SDT. The objective of this article is to provide an extensive overview of the clinical and preclinical research conducted in vivo on SDT, to identify the limitations, and to detail the developed strategies to overcome them. 相似文献
52.
Alessandro Vatrella Angelantonio Maglio Corrado Pelaia Girolamo Pelaia Carolina Vitale 《Expert opinion on pharmacotherapy》2020,21(12):1505-1515
ABSTRACT
Introduction
‘Critical Asthma Syndrome’ (CAS) is an umbrella term proposed to include several forms of asthma, responsible for acute and life-threatening exacerbations. CAS requires urgent and adequate supportive and pharmacological treatments to prevent serious outcomes. 相似文献53.
An-feng TAO Zheng-hao XU Cheng-hao WU Yi WANG Wei-wei HOU Shi-hong ZHANG Zhong CHEN 《浙江大学学报(医学版)》2015,44(3):315
目的观察比较不同脉冲波形的低频率电刺激对海马电点燃癫痫模型小鼠的作用差异。方法采用电点燃刺激法建立小鼠癫痫模型, 观察正弦波、单相方波、双相方波低频率电刺激对模型小鼠癫痫行为发作及后放电持续时间的影响, 并比较不同时间点给予正弦波低频率电刺激的抗癫痫作用。结果与对照组比较, 正弦波低频率电刺激30 s能降低小鼠海马电点燃癫痫发作等级(2.85 ± 0.27 vs 4.75 ±0.12, P < 0.05)、减少大发作概率(53.6% vs 96.5%, P < 0.01) 和缩短后放电持续时间[(16.22 ± 1.69) s vs (30.29 ± 1.12) s, P < 0.01], 而单相方波和双相方波低频率电刺激30 s没有明显的抗癫痫作用。常用的单相方波低频率电刺激15 min能降低小鼠海马电点燃发作等级(3.58 ± 0.16, P < 0.05)、减少大发作概率(66.7%, P < 0.01);但对海马后放电持续时间及大发作持续时间无影响(均 P>0.05)。此外, 电点燃刺激前预先给予或结束后3 s内给予正弦波低频率电刺激具有明显的抗癫痫作用( P < 0.05或 P < 0.01), 而电点燃刺激结束10 s给予正弦波低频率电刺激则无上述抗癫痫作用。 结论低频率电刺激抗癫痫作用受波形参数的影响, 其中正弦波低频率电刺激能有效抑制小鼠海马电点燃癫痫的发作。 相似文献
54.
《Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society》2020,28(11):1412-1426
55.
56.
Rosario Gulias-Cañizo Anell Lagunes-Guillén Arturo González-Robles Erika Sánchez-Guzmán Federico Castro-Muñozledo 《Burns : journal of the International Society for Burn Injuries》2019,45(2):398-412
Background
Since recent reports have shown that (-)-Epigallocatechin-3-gallate (EGCG) could be used for treating proliferative and inflammatory disorders, we explored its use for the management of corneal chemical burns.Materials and methods
Initially, EGCG was assayed on the rabbit corneal epithelial cell line RCE1(5T5) to establish the best testing conditions, and to avoid unwanted outcomes in the experimental animals. Then, we studied its effects on cell proliferation, cell cycle progression and cell differentiation. Afterwards, we instilled EGCG in experimental grade II corneal alkali burns in mice, three times a day up to 21 days, and evaluated by slit lamp examination and histological sections of corneal epithelial, corneal endothelial and stromal edema, as well as the presence of inflammatory cells and neovascularization.Results
EGCG reduced cell growth and led to a decline in the proportion of proliferative cells in a concentration dependent manner. At 10 μM, EGCG promoted cell differentiation, an effect not related with apoptosis or cytotoxicity. When 10 μM EGCG was instilled in corneal alkali burns in mice three times a day up to 21 days, EGCG significantly reduced corneal opacity and neovascularization. The improved clinical appearance of the cornea was associated to a controlled epithelial growth; epithelial morphology was similar to that observed in normal epithelium and contrasted with the hyperproliferative, desquamating epithelium observed in control burn wounds. EGCG reduced corneal, stromal and endothelial edema, and wound inflammation.Conclusion
This work constitutes the first evidence for the use of EGCG in the acute phase of a corneal alkali burn, representing a possible novel alternative to improve patient outcomes as an add-on therapy. 相似文献57.
58.
59.
60.
《Neuromodulation》2021,24(2):337-342
ObjectiveTo explore the utility of deep brain stimulation (DBS) telemedicine in the management of patients with movement disorders from January 2019 to March 2020, covering the main period of the COVID-19 outbreak in China.Materials and MethodsWe obtained data from 40 hospitals around China that employed DBS tele-programming for their outpatients with Parkinson’s disease or dystonia from January 2019 to March 2020. Data were obtained on the number and nature of patients’ DBS health care service requests, reasons for their requests, the number of DBS telemedicine sessions subsequently completed, safety issues, and the patients’ satisfaction with the DBS tele-programing parameter adjustments made.ResultsThere were 909 DBS tele-programming health service requests (from 196 patients) completed during the study period. The results showed: 1) the number of DBS telemedicine sessions requested and the number of patients examined increased during the COVID-19 outbreak in February and March 2020 when compared with the monthly numbers in 2019; 2) the most common reason for the patients’ health service requests was poor symptom control; 3) the most common DBS tele-programming adjustment made was voltage change; 4) overall, most (89%) DBS tele-programming adjustment sessions were experienced by the patients as satisfactory; and 5) significant adverse events and unexpected treatment interruptions caused by connection failure or other hardware- or software-related problems did not occur.ConclusionsDBS telemedicine could have a unique role to play in maintaining the delivery of DBS treatment and medical care to outpatients with movement disorders during the COVID-19 pandemic. 相似文献